跳至主要内容
临床试验/NCT02369575
NCT02369575撤回不适用

Identification of Novel Markers of Human Lung Disease

Ohio State University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2015年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
100
试验地点
1
主要终点
The development of novel therapeutics for interstial lung disease

研究概览

简要总结

The purpose of this study is to investigate new therapies for advanced lung disease.

详细描述

This research study is being conducted to learn about the progression and cause of lung disease. By agreeing to be a part of this study, you will allow the lung tissue which would normally have been discarded after your procedure, to be used for research purposes to allow us to understand more about your condition which may potentially lead to novel treatments and therapeutics. For this study, the investigators will isolate specific cells from the lung tissue and measure cellular, molecular and genetic mechanisms responsible for regulating lung disease. No other type of research will be performed on these samples nor will the samples be given to other investigators for unrelated research.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • any one on lung transplant list

排除标准

  • HIV positive

结局指标

主要结局

The development of novel therapeutics for interstial lung disease

时间窗: 10 years

Our research on these human lung cells will provide critical data which will aid in the diagnosis and treatment of a variety of different lung diseases, which have no cure.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Megan Ballinger

Research Asst Professor

Ohio State University

研究点 (1)

Loading locations...

相似试验